Intranasal Oxytocin for Infants With Prader-Willi Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to compare the change in suck and swallow competency from baseline to morning of day 6 with intranasal oxytocin spray vs placebo in infants/children with Prader-Willi Syndrome who are in nutritional phase 1a. Videofluoroscopic swallow studies will be performed on treatment day 1 and on the day following treatment morning of day 6.
Epistemonikos ID: 5354d7a63a430f472f9c119db1698f7a4d86a3f9
First added on: May 21, 2024